Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

VCC-1 Activators

VCC-1 Activators are a diverse group of chemical compounds that indirectly promote the functional activity of VCC-1, primarily through modulating receptor interactions and immune cell functions. Compounds like SB225002, Reparixin, and SCH527123, which are CXCR2 antagonists, play a pivotal role in enhancing VCC-1 activity. By reducing competitive binding at CXCR2, these compounds increase the availability of CXCL17 receptors, which are crucial for VCC-1 binding and subsequent activation. This mechanism is especially significant in facilitating VCC-1 mediated chemotactic signaling, which is central to its role in immune modulation. Furthermore, macrolide antibiotics such as Azithromycin and Clarithromycin, known for their anti-inflammatory properties, can indirectly augment VCC-1 activity. They achieve this by modulating macrophage functions, which in turn could increase CXCL17 receptor expression, thus enhancing the potential for VCC-1 interaction and activity.

Additionally, PPAR-gamma agonists like Rosiglitazone and Pioglitazone contribute to the enhancement of VCC-1 activity. They exert their effects by influencing macrophage polarization, a process that can affect the dynamics of CXCL17 receptors relevant for VCC-1 interaction. This modulation of macrophage function is crucial for optimizing the immunomodulatory effects of VCC-1. Natural compounds such as Curcumin, Resveratrol, and Sulforaphane, known for their anti-inflammatory properties, further support VCC-1 activity. These compounds modulate immune cell functions, potentially affecting the availability of CXCL17 receptors for effective VCC-1 engagement. Vitamin D3, through its immunomodulatory effects, also plays a role in enhancing VCC-1 activity by influencing macrophage function and, consequently, CXCL17 receptor expression. Omega-3 Fatty Acids, particularly EPA and DHA, augment VCC-1 activity through their anti-inflammatory effects, which can influence CXCL17 receptor dynamics, facilitating effective VCC-1 interaction. Together, these VCC-1 Activators, through their targeted effects on receptor interactions and immune cell modulation, facilitate the enhancement of VCC-1 mediated functions, crucial for orchestrating effective immune responses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 225002

182498-32-4sc-202803
sc-202803A
1 mg
5 mg
$36.00
$102.00
2
(1)

SB225002, a CXCR2 antagonist, indirectly enhances VCC-1 activity by reducing competitive binding at CXCR2, potentially increasing the availability of CXCL17 receptors for VCC-1 binding and activation.

Lonafarnib

193275-84-2sc-482730
sc-482730A
5 mg
10 mg
$173.00
$234.00
(0)

Reparixin, another CXCR2 inhibitor, can indirectly augment VCC-1 activity by minimizing competition at the receptor, facilitating VCC-1 mediated chemotactic signaling.

Azithromycin

83905-01-5sc-254949
sc-254949A
sc-254949B
sc-254949C
sc-254949D
25 mg
50 mg
500 mg
1 g
5 g
$52.00
$103.00
$260.00
$364.00
$728.00
17
(1)

Azithromycin, known for its anti-inflammatory properties, may indirectly enhance VCC-1 activity by modulating macrophage functions, which could increase CXCL17 receptor availability for VCC-1.

Clarithromycin

81103-11-9sc-205634
sc-205634A
100 mg
250 mg
$77.00
$122.00
1
(1)

Clarithromycin, similar to Azithromycin, could indirectly enhance VCC-1 activity by affecting macrophage activity, possibly leading to increased CXCL17 receptor expression for VCC-1 interaction.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Rosiglitazone, a PPAR-gamma agonist, may indirectly increase VCC-1 activity by modulating macrophage polarization, which can affect CXCL17 receptor dynamics relevant for VCC-1.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Pioglitazone, another PPAR-gamma agonist, potentially enhances VCC-1 activity indirectly by influencing macrophage polarization and CXCL17 receptor expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin, with its anti-inflammatory properties, may indirectly enhance VCC-1 activity by modulating immune cell function, potentially affecting CXCL17 receptor availability for VCC-1.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol, known for its anti-inflammatory effects, could indirectly enhance VCC-1 activity by modulating immune responses, which may influence CXCL17 receptor dynamics for VCC-1.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Vitamin D3, through its immunomodulatory effects, may indirectly enhance VCC-1 activity by influencing macrophage function and CXCL17 receptor expression relevant to VCC-1.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane, with its impact on inflammatory pathways, could indirectly enhance VCC-1 activity by modulating immune cell functions, potentially affecting CXCL17 receptor availability for VCC-1.